Cannabidiol (CBD), a non-psychoactive compound derived from Cannabis Sativa, has
garnered increasing attention for its diverse therapeutic potential. This comprehensive …

Neurodegenerative disorders (NDs) such as Alzheimer's disease, Parkinson's disease,
Huntington's disease, multiple sclerosis, and amyotrophic lateral sclerosis are severe and …

Cannabinoids, the bioactive compounds found in Cannabis sativa, have been used for
medicinal purposes for centuries, with early discoveries dating back to the BC era (BCE) …

Cardiovascular disease (CVD) remains a major health burden despite significant
therapeutic advances accomplished over the last decades. It is widely and increasingly …

Endocannabinoids were implicated in a variety of pathological conditions including anxiety
and are considered promising new targets for anxiolytic drug development. The optimism …

Background The NLRP3 inflammasome is a vital player in the emergence of inflammation.
The priming and activation of the NLRP3 inflammasome is a major trigger for inflammation …

Introduction The involvement of endocannabinoid system (ECS) in the inflammatory
cascade, and the ability of phytocannabinoids, endocannabinoids and their synthetic …

The term extrapyramidal disorders is most often used for conditions such as Parkinson's
disease or Huntington's disease, but also refers to a group of extrapyramidal side effects of …

Cannabis sativa, a versatile plant with numerous varieties, holds promising potential for a
wide range of biological activity. As raw materials for research, we chose leaves and …

Sepsis-induced renal damage poses a significant threat, necessitating effective therapeutic
strategies. Cannabidiol (CBD) has beneficial effects on tissues and their functions by …